abstract |
The present disclosure relates to methods of characterizing a CD73 antagonist, which method is suitable as a potency assay. The assay provided herein determines the ability of a CD73 antagonist to inhibit the CD73 -mediated enzymatic conversion of AMP to adenosine. In vitro assays, including those with a CD73 antagonist reference sample, are also provided. |